|
|
|
|
|
HONG KONG, Nov 5, 2014 - (ACN Newswire) - China Pioneer Pharma Holdings Limited, the leading comprehensive marketing, promotion and channel management service providers dedicated to imported pharmaceutical products and medical devices in China, today announced Taiwan's Food and Drug Administration has approved the launch of NovaBay Pharmaceuticals, Inc.'s medical devices product NeutroPhase Skin and Wound Cleanser for sale in Taiwan. China Pioneer Pharma will launch NeutroPhase in Taiwan in early 2015. NeutroPhase previously has been approved for sale throughout mainland China, Singapore, Malaysia and the United States. China Pioneer Pharma owns about 15% of NovaBay's shares, making it NovaBay's largest shareholder, and is also the exclusive distributor for NeutroPhase in mainland China and throughout Southeast Asia.
NeutroPhase contains Neutrox(TM), NovaBay's proprietary, manufactured pure hypochlorous acid solution which mimics a substance produced naturally by the immune system as a first defense against microbial invaders. Laboratory tests show that Neutrox not only kills bacteria that infect wounds and cause necrotizing fasciitis, it also neutralizes toxins produced by both bacteria and the immune system that impede healing and destroy healthy tissue. Those properties enable NeutroPhase to be useful as an advanced wound cleanser in the management of acute and chronic infections, allowing the body to progress toward healing.
Mr. LI Xinzhou, Chairman, Executive Director and Chief Executive Officer of China Pioneer Pharma said, "China Pioneer Pharma will be working with local distributers to sell NeutroPhase products in Taiwan. We believe that NeutroPhase can bring a major improvement in medical care. This will help address major unmet medical needs to more physicians and patients, bring them a new tool in managing chronic non-healing wounds, such as diabetic ulcers, and in treating acute infections like flesh-eating disease."
Topic: Press release summary
Source: China Pioneer Pharma Holdings Limited
Sectors: Daily Finance, Daily News, Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
